Takeda Pharmaceutical Ratios (2018-2025) | TAK

Ratios Mar2018 Mar2019 Mar2020 Mar2021 Mar2022 Mar2023 Mar2024 Mar2025
Efficiency
Inventory Average 5.16B7.67B7.05B7.23B7.40B7.81B8.07B
Equity Average 32.86B45.26B46.17B48.92B48.48B48.56B47.27B
Invested Capital 27.71B99.34B90.20B92.70B86.32B81.17B81.77B75.06B
Leverage & Solvency
Debt to Equity 0.501.111.080.940.760.690.670.65
Valuation
Enterprise Value -3.46B49.50B41.51B47.42B37.25B46.91B40.39B44.48B
Market Capitalization 56.09B47.51B56.89B44.77B51.10B43.58B47.14B